2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Disease
3
Prostatic Neoplasms
2
Hereditary Cancer
2
Colorectal Neoplasms
2
Sarcoma, Kaposi
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pain
1
Neoplasms
1
Lung Neoplasms
1
Gynecologic Cancer
1
Genetic Diseases, Inborn
1
Development of the Virtual Biopsy
1
Colorectal Neoplasms, Hereditary Nonpolyposis
1
Colonic Neoplasms
1
Chronic Pain
1
Castleman Disease
1
Cancer Pain
1
COVID-19
1
Breast Neoplasms
1
Brain Neoplasms
1
Anus Neoplasms
1
Adenoma
1
Interventions
Fluorouracil
26
Radiotherapy
18
Mitomycin
17
Cisplatin
12
Capecitabine
12
pembrolizumab
10
Magnetic Resonance Spectroscopy
9
Cyclophosphamide
9
Radiation
8
Paclitaxel
8
Biopsy
8
fludarabine
7
Specimen Handling
7
Nivolumab
7
Drug Therapy
7
Carboplatin
7
Surveys and Questionnaires
6
Cetuximab
6
Papillomavirus Vaccines
5
dehydroftorafur
4
aldesleukin
4
Vaccines
4
Radiotherapy, Intensity-Modulated
4
Observation
4
Irinotecan
4
Watchful Waiting
3
Taxes
3
Oxaliplatin
3
Light Coagulation
3
Ipilimumab
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Anus Neoplasms
×
Diagnostic Tests, Routine
×
Clear all
NCT05217940
2025-08-22
SWAN
Icahn School of Medicine at Mount Sinai
Phase NA
Recruiting
300 enrolled